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Rationale and Objectives
•

Factors associated with local failure and death from lung cancer were evaluated
based on post-treatment FDG-PET imaging in patients (pts) with non-small cell
lung cancer (NSCLC).

•

PET-CT scans were obtained 6-8 weeks after thoracic RT and approximately
every 3 months thereafter.

Materials and Methods
•

•

•

•

Results: Metabolic Response After RT
Metric

Pre-RT

Post-RT #1

Post-RT #2

Tumor Max SUV

12.3
(1.9-31)

3.4
(0.9-20.9)

2.9
(1-22.5)

Lymph nodes
Max SUV

9.1
(2-23.7)

2.8
(1.5-7.9)

2.8
(1.5-8.9)

51.1 cc
(1.5-491)

37.3 cc
(3-585)

22.9 cc
(2-153)

MTV (tumor +
lymph nodes)

Slow Post-RT Tumor Response
1

2

Maximum SUV (MaxSUV) and the Metabolic Tumor Volume (MTV) of the
primary tumor and involved lymph nodes were measured using the same
software.
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Number (range)

Gender F:M

33 : 17

Median age

63

I

5

III

29

IV

11

recurrent

5
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Variables Associated with Local Failure:
Multivariate Analysis

Local failure was defined as increase in MaxSUV of either the primary
tumor or lymph nodes in the RT field, with any accompanying increase
in size of the tumor on a CT scan.

Variable

HR

p-value

Age

0.98

0.46

Sex (F/M)

0.81

0.76

Stage

15.35

0.009

BED RT total dose Lo/Hi1

2.15

0.31

Pre-treatment MTV

3.45

0.19

Change in MTV
(continuous)

10.45

0.057

5.9

0.44

0.082

0.045

Pre-treatment SUV

Characteristic
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Fig.1. Local failure in Patients with Stages I-III

Results: Patient Characteristics

Stage:
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Statistics: MTV and Max SUV were assessed longitudinally, providing for each
patient separate log transformed initial estimates and changes (value at time
0 - value at time 1). Competing risks analysis of time to local failure and death
were completed using the methods of Gray (Gray RJ, J Ann Stat 1988;
16:1141–1154.), as implemented in the R package CMPRSK. Results are
reported as hazard ratios, 95% confidence interval of hazard ratio, and 2-sided
p-values.
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Patient Population: 50 pts with NSCLC who received thoracic RT (with or
without chemotherapy) between 2004-2008 were eligible if they had pre-RT
PET scan and at least one post-RT PET scan.
Methods: Primary tumor and hypermetabolic lymph nodes included in the RT
field were contoured on the initial and post-treatment PET scans applying a
gradient “PET edge” technique (Mimvista Corp, Cleveland, OH). PET edge is
superior to the percent threshold techniques (i.e. 25%, 30% max SUV etc)
(Nelson A et al, ASTRO 2009 abstract #2993) with regard to reflecting true
tumor volume.
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Change in SUV

Variables Associated with Death:
Multivariate Analysis
Variable

Fig.2. Local failure in Patients with Stage IV

Median RT dose
BED dose

60 (range 35-71)
73.2

Number of pts with post-RT
PET scans

50 (1 PET scan)
26 (2 scans)
11 (3 scans)
4 (4 scans)
4 (5 scans)
3 (6 scans)

HR

p-value

Age

1.035

0.17

Sex (F/M)

6.21

0.11

Stage

1.44

0.79

BED RT total dose Lo/Hi

0.29

0.31

Pre-treatment MTV (categor.)

6.36

0.016

Change in MTV

0.24

0.11

Pre-treatment SUV (contin.)

1.05

0.037

Change in SUV

0.54

0.79

Conclusions

Results
•

A total of 262 primary tumors and/or lymph nodes were analyzed.

•

Median FU time: 14.2 mo (range 2-52.2)

•

Metabolic complete response (mCR, SUV2.5) was achieved in 38% patients.
LF occurred in 10 pts.
1st

post-RT PET;

•

The primary tumor median MaxSUV declined by 72% by the
76% by the 2nd and 77% by the 3rd.

•

Median time to local failure (LF) not reached (75th %: 24 mo); MST 31 mo.

Legend to Figures 1 and 2:
Blue = hi change in MTV, low change in SUV
Red = low change in MTV, low change in SUV
Turquoise = high change in MTV, high change in SUV
Green =low change in MTV, high change in SUV

•

LF after thoracic RT is not common (20%) during lifetime of pts receiving 3D
thoracic RT and the rate of metabolic response is rapid.

•

Higher pre-treatment maximum SUV and MTV>51 cc are associated with
increased risk of death from lung cancer.

•

Rapid post-treatment decline in SUV on first follow-up PET scan is associated
with subsequent lower risk of local failure.

•

However, the decline in MTV was paradoxically associated with eventual
increased failure. We hypothesize this may be related to the aggressive
tumors which respond quickly yet recur faster.

•

Patients with Stage IV lung cancer are more likely to experience local failure
than lower stage patients, which may be due to the lower thoracic RT doses.

